Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, co- promotes INTEGRILIN(R) (eptifibatide) Injection, a market-leading cardiovascular product and has a robust clinical development pipeline of product candidates. The Company’s research, development and commercialization activities are focused in three therapeutic areas: oncology, cardiovascular and inflammation. By applying its knowledge of the human genome, its understanding of disease mechanisms and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products. ( www.millennium.com )
Millennium Pharmaceuticals , Inc.
40 Landsdowne Street
Cambridge, Massachusetts 02139
USA
Tel: (617) 679-7000
Fax: (617) 374-7788